Header cover image

Swiss (SMI) Biotech Industry Analysis

UpdatedJun 17, 2026
DataAggregated Company Financials
Companies4
  • 7D1.2%
  • 3M-13.2%
  • 1Y-11.4%
  • YTD-25.2%

In the last week, the Biotech industry is up 1.4%, with Idorsia up 10%. Meanwhile, MindMaze Therapeutics Holding actually underperformed within the industry, shrinking 26% in the last week. In contrast, the industry has lost 15% in the last 12 months. Earnings are forecast to grow by 37% annually.

Industry Valuation and Performance

Has the Swiss Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Jun 2026CHF 1.6bCHF 348.9m-CHF 25,736,944.64211.5x-60.8x4.5x
Fri, 15 May 2026CHF 1.7bCHF 346.8m-CHF 15,854,555.22218.6x-105.1x4.8x
Sun, 12 Apr 2026CHF 1.8bCHF 347.6m-CHF 19,468,235.80254.7x-92.4x5.2x
Tue, 10 Mar 2026CHF 1.9bCHF 335.7m-CHF 25,892,000.0016.1x-73.6x5.7x
Thu, 05 Feb 2026CHF 2.0bCHF 339.6mCHF 6.5m9.7x310.3x6x
Sat, 03 Jan 2026CHF 2.2bCHF 339.6mCHF 6.5m9.3x331.7x6.4x
Mon, 01 Dec 2025CHF 2.0bCHF 343.6m-CHF 10,514,000.008.3x-191.4x5.9x
Wed, 29 Oct 2025CHF 1.9bCHF 344.3m-CHF 15,083,000.007.9x-123.1x5.4x
Fri, 26 Sep 2025CHF 1.6bCHF 344.3m-CHF 15,083,000.007.8x-105.4x4.6x
Sun, 24 Aug 2025CHF 1.9bCHF 385.0m-CHF 51,743,000.008x-37.4x5x
Tue, 22 Jul 2025CHF 2.1bCHF 333.9m-CHF 44,705,000.008.5x-46.2x6.2x
Thu, 19 Jun 2025CHF 1.9bCHF 333.9m-CHF 44,705,000.007.9x-42.5x5.7x
Sat, 17 May 2025CHF 1.8bCHF 333.9m-CHF 44,705,000.007x-39.5x5.3x
Mon, 14 Apr 2025CHF 1.5bCHF 411.1mCHF 65.6m4.4x22.1x3.5x
Wed, 12 Mar 2025CHF 1.7bCHF 409.3m-CHF 35,110,868.005x-47.1x4x
Fri, 07 Feb 2025CHF 1.8bCHF 330.3m-CHF 75,131,868.003.4x-23.5x5.3x
Sun, 05 Jan 2025CHF 1.7bCHF 330.3m-CHF 75,131,868.002.8x-22.8x5.2x
Tue, 03 Dec 2024CHF 1.6bCHF 330.9m-CHF 87,805,465.001.6x-18.4x4.9x
Thu, 31 Oct 2024CHF 1.9bCHF 333.1m-CHF 82,023,629.001.7x-22.9x5.6x
Sat, 28 Sep 2024CHF 1.6bCHF 333.6m-CHF 81,088,264.001.7x-19.1x4.6x
Mon, 26 Aug 2024CHF 1.4bCHF 319.7m-CHF 142,008,264.001.9x-10x4.4x
Wed, 24 Jul 2024CHF 759.9mCHF 151.7m-CHF 146,197,264.001.6x-5.2x5x
Fri, 21 Jun 2024CHF 841.8mCHF 151.7m-CHF 146,197,264.001.6x-5.8x5.5x
Sun, 19 May 2024CHF 538.2mCHF 170.3m-CHF 131,508,021.161x-4.1x3.2x
Tue, 16 Apr 2024CHF 443.1mCHF 67.6m-CHF 173,113,459.400.09x-2.6x6.6x
Thu, 14 Mar 2024CHF 338.4mCHF 55.5m-CHF 173,248,004.840.3x-2x6.1x
Sat, 10 Feb 2024CHF 370.6mCHF 55.4m-CHF 173,281,198.021x-2.1x6.7x
Mon, 08 Jan 2024CHF 324.0mCHF 317.4m-CHF 176,097,332.000.5x-1.8x1x
Wed, 06 Dec 2023CHF 341.7mCHF 317.9m-CHF 209,011,437.00n/a-1.6x1.1x
Fri, 03 Nov 2023CHF 258.1mCHF 318.6m-CHF 211,390,599.00n/a-1.2x0.8x
Sun, 01 Oct 2023CHF 262.4mCHF 318.6m-CHF 213,557,748.00n/a-1.2x0.8x
Tue, 29 Aug 2023CHF 301.3mCHF 318.7m-CHF 188,662,518.00n/a-1.6x0.9x
Thu, 27 Jul 2023CHF 338.4mCHF 320.3m-CHF 179,711,882.00n/a-1.9x1.1x
Sat, 24 Jun 2023CHF 306.0mCHF 331.2m-CHF 180,872,814.00n/a-1.7x0.9x
Price to Earnings Ratio

-1.7x


Total Market Cap: CHF 306.0mTotal Earnings: -CHF 180,872,814.00Total Revenue: CHF 331.2mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Biotech Industry Price to Earnings3Y Average -13.6x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swiss Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 4.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market2.62%
Healthcare0.98%
Biotech1.18%
Biotech1.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IDIA IdorsiaCHF 4.656.2%
+CHF 68.9m
131.3%PS5.4x
BSLN Basilea PharmaceuticaCHF 50.403.7%
+CHF 22.3m
0.4%PE15.5x
MOLN Molecular PartnersCHF 3.132.3%
+CHF 2.6m
1.0%PB1.7x

Latest News